GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (LSE:CTEC) » Definitions » 3-Year EBITDA Growth Rate

ConvaTec Group (LSE:CTEC) 3-Year EBITDA Growth Rate : 4.40% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is ConvaTec Group 3-Year EBITDA Growth Rate?

ConvaTec Group's EBITDA per Share for the six months ended in Dec. 2023 was £0.09.

During the past 12 months, ConvaTec Group's average EBITDA Per Share Growth Rate was 27.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 4.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 0.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of ConvaTec Group was 17.60% per year. The lowest was -12.60% per year. And the median was 3.55% per year.


Competitive Comparison of ConvaTec Group's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, ConvaTec Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ConvaTec Group's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ConvaTec Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where ConvaTec Group's 3-Year EBITDA Growth Rate falls into.



ConvaTec Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


ConvaTec Group  (LSE:CTEC) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


ConvaTec Group 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of ConvaTec Group's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


ConvaTec Group (LSE:CTEC) Business Description

Traded in Other Exchanges
Address
23 Forbury Road, 3 Forbury Place, Reading, GBR, RG1 3JH
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and continence care are the largest divisions, accounting for 30% and 26% of total revenue, respectively. Ostomy contributes 25% of revenue and infusion sets 19%.

ConvaTec Group (LSE:CTEC) Headlines